DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,042 filers reported holding DANAHER CORPORATION in Q3 2023. The put-call ratio across all filers is 0.89 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $6,312,000 | +48.2% | 26,300 | +55.6% | 0.16% | +44.1% |
| Q1 2023 | $4,259,476 | +71224.1% | 16,900 | -24.9% | 0.11% | -38.7% |
| Q4 2022 | $5,972 | -99.8% | 22,500 | +129.6% | 0.18% | +118.1% |
| Q3 2022 | $2,531,000 | -45.7% | 9,800 | -46.7% | 0.08% | -38.1% |
| Q2 2022 | $4,665,000 | -7.9% | 18,400 | +19.5% | 0.13% | +30.1% |
| Q4 2021 | $5,067,000 | -28.3% | 15,400 | -33.6% | 0.10% | -29.0% |
| Q3 2021 | $7,063,000 | -8.0% | 23,200 | -18.9% | 0.14% | -7.6% |
| Q2 2021 | $7,675,000 | +138.4% | 28,600 | +100.0% | 0.16% | +121.1% |
| Q1 2021 | $3,219,000 | -6.5% | 14,300 | -7.7% | 0.07% | -6.6% |
| Q4 2020 | $3,443,000 | -23.9% | 15,500 | -26.2% | 0.08% | -38.2% |
| Q3 2020 | $4,522,000 | +69.4% | 21,000 | +39.1% | 0.12% | +57.7% |
| Q2 2020 | $2,670,000 | -47.6% | 15,100 | -59.0% | 0.08% | -57.8% |
| Q1 2020 | $5,093,000 | +17.3% | 36,800 | +30.0% | 0.18% | +49.2% |
| Q4 2019 | $4,343,000 | -33.0% | 28,300 | -37.0% | 0.12% | -35.8% |
| Q3 2019 | $6,485,000 | -1.1% | 44,900 | -2.2% | 0.19% | +2.1% |
| Q2 2019 | $6,560,000 | -16.2% | 45,900 | -22.6% | 0.19% | -17.1% |
| Q1 2019 | $7,829,000 | -14.0% | 59,300 | -29.2% | 0.23% | -3.0% |
| Q3 2018 | $9,106,000 | +1.1% | 83,800 | -8.2% | 0.24% | -3.7% |
| Q2 2018 | $9,009,000 | +0.4% | 91,300 | -0.3% | 0.24% | +5.2% |
| Q1 2018 | $8,969,000 | -3.3% | 91,600 | -8.4% | 0.23% | +10.0% |
| Q4 2017 | $9,279,000 | -7.0% | 99,973 | -14.0% | 0.21% | -9.8% |
| Q3 2017 | $9,976,000 | -6.8% | 116,300 | -8.3% | 0.23% | -11.7% |
| Q2 2017 | $10,701,000 | +6.9% | 126,800 | +8.4% | 0.26% | +12.8% |
| Q1 2017 | $10,007,000 | +19.6% | 117,000 | +8.8% | 0.24% | +2.6% |
| Q4 2016 | $8,368,000 | +137.7% | 107,500 | +139.4% | 0.23% | +143.6% |
| Q3 2016 | $3,520,000 | -25.4% | 44,900 | -3.9% | 0.09% | -21.7% |
| Q2 2016 | $4,717,000 | +12.3% | 46,700 | +5.4% | 0.12% | +9.1% |
| Q1 2016 | $4,202,000 | -17.0% | 44,300 | -18.7% | 0.11% | -24.1% |
| Q4 2015 | $5,062,000 | -13.3% | 54,500 | -20.4% | 0.14% | -15.2% |
| Q3 2015 | $5,837,000 | +29.9% | 68,500 | +30.5% | 0.17% | +31.5% |
| Q2 2015 | $4,493,000 | -15.6% | 52,500 | -16.3% | 0.13% | -13.9% |
| Q1 2015 | $5,323,000 | +10.7% | 62,700 | +11.8% | 0.15% | +36.0% |
| Q4 2014 | $4,808,000 | -32.8% | 56,100 | -40.4% | 0.11% | -33.9% |
| Q3 2014 | $7,150,000 | +21.7% | 94,100 | +26.1% | 0.17% | +30.2% |
| Q2 2014 | $5,873,000 | -42.3% | 74,600 | -45.0% | 0.13% | -45.1% |
| Q1 2014 | $10,178,000 | +1.8% | 135,700 | +4.8% | 0.24% | -0.4% |
| Q4 2013 | $9,997,000 | +10.4% | 129,500 | -0.8% | 0.24% | +2.2% |
| Q3 2013 | $9,053,000 | +1.4% | 130,600 | -7.4% | 0.23% | -0.4% |
| Q2 2013 | $8,932,000 | – | 141,100 | – | 0.23% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RobecoSam USA, Inc. | 74,961 | $7,572,000 | 9.43% |
| Corvid Peak Capital Management, LLC | 250,000 | $25,250,000 | 8.54% |
| CORTLAND ASSOCIATES INC/MO | 310,508 | $31,361,000 | 6.88% |
| Southpoint Capital Advisors LP | 1,250,000 | $126,250,000 | 6.75% |
| GREEN VALLEY INVESTORS LLC | 2,168,594 | $219,027,000 | 6.70% |
| DAVIS-REA LTD. | 75,080 | $7,595,000 | 5.39% |
| CADINHA & CO LLC | 247,143 | $24,961,000 | 5.35% |
| Espalier Global Management LLC | 47,100 | $4,757,000 | 5.25% |
| Spears Abacus Advisors LLC | 398,334 | $40,232,000 | 5.10% |
| GCA INVESTMENT MANAGEMENT, LLC | 158,064 | $15,964,000 | 5.01% |